Free Trial

Medpace Q2 2024 Earnings Report

Medpace logo
$347.52 +10.17 (+3.01%)
As of 04:00 PM Eastern

Medpace EPS Results

Actual EPS
$2.75
Consensus EPS
$2.54
Beat/Miss
Beat by +$0.21
One Year Ago EPS
$1.93

Medpace Revenue Results

Actual Revenue
$528.10 million
Expected Revenue
$528.41 million
Beat/Miss
Missed by -$310.00 thousand
YoY Revenue Growth
+14.60%

Medpace Announcement Details

Quarter
Q2 2024
Time
After Market Closes

MEDP Upcoming Earnings

Medpace will be holding an earnings conference call on Tuesday, February 11 at 9:00 AM Eastern. Interested parties can register for or listen to the call.

Conference Call Resources

Medpace Earnings Headlines

AAPL: Double Your Returns in 24 Hours?
Trader Chris Pulver is diving deep into the inner workings of Wall Street... To reveal a trading method he’s kept under wraps for years. You see… Thanks to “liquidity levels” which show us Wall Street’s biggest undercover buy orders in real time… This method has shown the ability to DOUBLE our returns…
See More Medpace Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Medpace? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medpace and other key companies, straight to your email.

About Medpace

Medpace (NASDAQ:MEDP) engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

View Medpace Profile

More Earnings Resources from MarketBeat